Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Drug Delivery
Filter     Order     Display # 
Date Item Title
30 Jun 2008 Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
25 Jun 2008 SurModics Announces Initiation by Merck & Co., Inc. of Phase IIb Clinical Trial for I-vation(TM) TA
25 Jun 2008 Promising Results for Oral CP-4126
12 Jun 2008 Lilly and TransPharma Medical Announce Licensing and Development Agreement
01 May 2008 Sepracor and Arrow Sign Global License and Development Agreement Covering Technology to Enhance Ciclesonide and BROVANA(R) Franchises
30 Apr 2008 Phosphagenics Reports Positive Pre-clinical Results for
30 Apr 2008 Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
29 Apr 2008 Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
16 Apr 2008 Proof of Concept Study in Second Species Demonstrates Increase in Absorption of Oral B12 Using Emisphere Technology
09 Apr 2008 Pfizer Statement on Exubera Labeling Update in the United States
09 Apr 2008 Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
02 Apr 2008 Pantec Biosolutions unveils preclinical data for novel transdermal drug delivery platform
30 Mar 2008 QLT initiates Phase II study of punctal plug drug delivery system for Glaucoma & Ocular Hypertension
30 Mar 2008 QLT initiates Phase II study of punctal plug drug delivery system for Glaucoma & Ocular Hypertension
19 Mar 2008 Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
19 Mar 2008 Phosphagenics Initiates its Phase 2 Clinical Trial in Type 1 Diabetes
13 Mar 2008 AstraZeneca signs drug delivery collaboration
12 Mar 2008 Unigene Successfully Completes Phase I/II Clinical Study for Oral Calcitonin
11 Mar 2008 Inovio Biomedical's Electroporation Delivery Technology Demonstrates Safety and Positive Clinical Responses with Melanoma DNA Immunotherapy
11 Mar 2008 Oramed Pharmaceuticals Successfully Completes Phase 1B Clinical Trials of Oral Insulin Capsule
11 Mar 2008 OctoPlus announces publication of Phase I Locteron results in the Journal of Interferon and Cytokine Research
07 Mar 2008 Lilly Announces Termination of AIR Insulin Program
07 Mar 2008 Alkermes Provides Update on Inhaled Insulin Program
03 Mar 2008 Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
25 Feb 2008 Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
19 Feb 2008 Phosphagenics Initiates US Clinical Trials For Its Topical Retinoic Acid
12 Feb 2008 Depomed Reports Positive Efficacy Data From a Phase 2 Trial of Gabapentin GR(TM) in the Treatment of Menopausal Hot Flashes
12 Feb 2008 Hana Biosciences Announces Top-Line Phase 1 Clinical Trial Data Demonstrating Alocrest to be Well-Tolerated With Promising Anti-Tumor Activity
11 Feb 2008 Bentley Pharmaceuticals Announces Completion of Treatment in Phase II India Clinical Study in Type 2 Diabetes and Preliminary Clinical Results
11 Feb 2008 Unigene Initiates Phase I/II Clinical Study for Oral Calcitonin
06 Feb 2008 OctoPlus commences United States Phase IIa study with Locteron for the treatment of hepatitis C
05 Feb 2008 Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
22 Jan 2008 Vyteris Announces First Successful Non-Invasive Delivery of Peptide Using Smart Patch Technology
22 Jan 2008 Oramed Pharmaceuticals Commences Phase 1B Clinical Trials
21 Jan 2008 iCo Therapeutics Provides iCo-009 (Oral Amphotericin B) Update
17 Jan 2008 YM BioSciences Provides Update on AeroLEF(TM) Clinical Development Program
09 Jan 2008 Amarin Announces Successful Outcome of Nasal Lorazepam Study
02 Jan 2008 NEOPHARM Announces IND Filing for Novel Liposomal Delivery System of Docetaxel
27 Dec 2007 VGX Pharmaceuticals Announces Successful Completion of the First Human Study to Assess the Tolerability of CELLECTRA(TM) Electroporator
27 Dec 2007 Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America
20 Dec 2007 Merck Serono and Flamel to Collaborate on an Extended Release Formulation for Therapeutic Proteins
20 Dec 2007 InSite Vision Initiates Pivotal Phase 3 Trials for AzaSite Plus(TM)
19 Dec 2007 Cystic Fibrosis: License Agreement Boosts Development of Therapy
18 Dec 2007 Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
17 Dec 2007 Successful transdermal oxycodone clinical trial results
07 Dec 2007 Submission of Marketing Authorisation Application for Dapoxetine in Europe
07 Dec 2007 Access Pharmaceuticals Demonstrates Ability To Significantly Reduce Glucose Levels in Pre-clinical Testing of
03 Dec 2007 Starpharma Signs Collaborative Research Agreement with Stiefel Laboratories, Inc.
28 Nov 2007 Transport’s Phase 2 Data Show Single Treatment SoloVir(TM) ETS Significantly Stops Progression of Cold Sore Episode
28 Nov 2007 Zosano Pharma, Inc. Closes Enrollment in Phase 2 Trial
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>
Results 1 - 50 of 401

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Integrin Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonistgs & Antagonists

Order Now

Subscribe La Merie Biologics